Home › Funds › Tetragon Partners GP Ltd › CUE

Tetragon Partners GP Ltd position in CUE

CUE BIOPHARMA · Health Care

Tetragon Partners GP Ltd reported holding 93,819 shares of CUE (CUE BIOPHARMA) in its Q2 2026 13F filing — a position valued at US$3.0M, representing 0.48% of its reported portfolio and ranking #28 among its reported holdings. Tetragon Partners GP Ltd first reported this position in Q2 2026.

Latest position (Q2 2026)93.82K sh
Reported value held$2.96M
Portfolio Weight0.48%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tetragon Partners GP Ltd's CUE position evolved

Tetragon Partners GP Ltd first disclosed a stake in CUE in Q2 2026 at 93,819 shares (US$3.0M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 93.82K $2.96M New

About CUE and 13F data

CUE (CUE BIOPHARMA) is a Health Care company. 28 other funds we track also report a position in CUE — the largest reported positions include Bleichroeder LP (US$11.7M), Lion Point Capital, LP (US$1.7M), Squadron Capital Management LLC (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CUE

All CUE fund holders →

FAQ

How long has Tetragon Partners GP Ltd held CUE?

Tetragon Partners GP Ltd has disclosed CUE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Tetragon Partners GP Ltd's current position in CUE?

As of Q2 2026, Tetragon Partners GP Ltd holds 93.82K shares of CUE (CUE BIOPHARMA), valued at $2.96M, representing 0.48% of its reported portfolio and ranking #28.

Has Tetragon Partners GP Ltd been buying or selling CUE?

In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd newly opened its position in CUE.

Which other funds hold CUE?

Other major institutional holders of CUE include Bleichroeder LP, Lion Point Capital, LP, Squadron Capital Management LLC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.